Cargando…
Unveiling the Yin-Yang Balance of M1 and M2 Macrophages in Hepatocellular Carcinoma: Role of Exosomes in Tumor Microenvironment and Immune Modulation
Hepatocellular carcinoma (HCC) is a primary liver cancer with a high mortality rate and limited treatment options. Recent research has brought attention to the significant importance of intercellular communication in the progression of HCC, wherein exosomes have been identified as critical agents fa...
Autores principales: | Papadakos, Stavros P., Machairas, Nikolaos, Stergiou, Ioanna E., Arvanitakis, Konstantinos, Germanidis, Georgios, Frampton, Adam Enver, Theocharis, Stamatios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453902/ https://www.ncbi.nlm.nih.gov/pubmed/37626849 http://dx.doi.org/10.3390/cells12162036 |
Ejemplares similares
-
Interplay of Extracellular Vesicles and TLR4 Signaling in Hepatocellular Carcinoma Pathophysiology and Therapeutics
por: Papadakos, Stavros P., et al.
Publicado: (2023) -
The Role of TLR4 in the Immunotherapy of Hepatocellular Carcinoma: Can We Teach an Old Dog New Tricks?
por: Papadakos, Stavros P., et al.
Publicado: (2023) -
Meeting at the Crossroad between Obesity and Hepatic Carcinogenesis: Unique Pathophysiological Pathways Raise Expectations for Innovative Therapeutic Approaches
por: Arvanitakis, Konstantinos, et al.
Publicado: (2023) -
Unraveling the Significance of EPH/Ephrin Signaling in Liver Cancer: Insights into Tumor Progression and Therapeutic Implications
por: Papadakos, Stavros P., et al.
Publicado: (2023) -
The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?
por: Papadakos, Stavros P., et al.
Publicado: (2023)